Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30.28M | $105.0M | 9.96% | +2.75M | 2026-03-31 |
| Capital World Investors | 13.36M | $46.0M | 4.40% | -- | 2026-03-31 |
| TD Waterhouse Canada Inc. | 9.56M | $33.0M | 3.15% | +9.54M | 2026-03-31 |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 7.58M | $26.0M | 2.49% | -301.2K | 2026-03-31 |
| Jefferies Financial Group Inc. | 5.48M | $19.0M | 1.80% | -- | 2026-03-31 |
| UBS Group AG | 4.21M | $14.0M | 1.38% | +2.27M | 2026-03-31 |
| ArrowMark Colorado Holdings LLC | 4.11M | $14.0M | 1.35% | -- | 2026-03-31 |
| BlackRock, Inc. | 4.04M | $14.0M | 1.33% | +174.3K | 2026-03-31 |
| Driehaus Capital Management LLC | 4.02M | $14.0M | 1.32% | -- | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 3.75M | $13.0M | 1.23% | -593.3K | 2026-03-31 |
